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Tracking antenatal HIV prevalence 
in South Africa
To the Editor: South Africa (SA) has been conducting annual cross-
sectional anonymous unlinked antenatal HIV seroprevalence surveys 
in sentinel sites (ANCHSS) for more than 20 years.[1] These sites are 
randomly selected using probability proportional to size sampling 
(PPS) methods as this combines a random approach with a bias 
towards larger clinics, resulting in a self-weighted sample.[1] First-
time antenatal attendees are enrolled into the ANCHSS, and blood 
for unlinked anonymous antenatal HIV testing (UAT) is drawn at the 
same time as first antenatal booking bloods.
Without refuting the usefulness of ANCHSS for tracking the 
antenatal HIV epidemic, five main concerns have recently been 
raised:[2] (i) high cost of ANCHSS implementation; (ii) high 
cost of duplicate HIV testing – every pregnant woman is tested 
anonymously for HIV infection using laboratory enzyme-linked 
immunoassay tests and is also routinely tested for HIV infection 
using clinic-based rapid tests; (iii) timing – the survey mainly 
measures HIV prevalence once during pregnancy; (iv) ethical – 
anonymous results are not returned to pregnant women; and (v) 
representativeness – sentinel sites may not be representative of the 
entire pregnant population.
Consequently new methods for antenatal HIV surveillance need 
investigation. Since the inception of the SA programme to prevent 
HIV transmission from mother to child (PMTCT), more than 95% 
of the healthcare system integrates PMTCT HIV testing into routine 
antenatal care.[3,4] Furthermore, the district health information system 
(DHIS), which gathers aggregate data from each facility in each 
district, has been updated to include routine data elements on HIV 
testing and HIV test results in general and among pregnant women. 
Data on second tests during pregnancy have also recently been added 
to the DHIS. 
A growing consensus has posited that, in the context of antiretroviral 
therapy, PMTCT expansion and DHIS strengthening, alternative 
surveillance methods and data sources are increasingly available 
and should be explored to address the concerns associated with 
UAT-based ANCHSS.[2] The World Health Organization developed 
guidelines for countries to evaluate the utility of routine data 
from PMTCT programmes ‘for HIV sentinel surveillance among 
pregnant women’ as outlined above.[2] These guidelines recognise the 
denominator and double counting problems with DHIS data, which 
require rectification.[5] 
This then begs the following questions: (i) should time and energy 
be invested in studying SA DHIS data and comparing these with SA 
ANCHSS data? (ii) should the quality of routine antenatal HIV testing 
procedures be assessed? and (iii) should SA ANCHSS be stopped?
We answer ‘yes’ to the first two questions, as strong routine 
monitoring systems are critical for management and planning. In 
addressing the third question, we believe that if routine data are used 
to monitor antenatal HIV prevalence, intermittent, periodic ANCHSS 
may still be needed to corroborate results. However, ANCHSS should 
be changed to linked, named testing to circumvent duplication and 
ethical issues. As our previous national work has shown that >95% of 
mothers accept named testing, uptake of antenatal HIV testing would 
not be significantly reduced by named, linked testing.[6]
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